Literature DB >> 21321073

Induction of experimental endocarditis by continuous low-grade bacteremia mimicking spontaneous bacteremia in humans.

T R Veloso1, M Amiguet, V Rousson, M Giddey, J Vouillamoz, P Moreillon, J M Entenza.   

Abstract

Transient high-grade bacteremia following invasive procedures carries a risk of infective endocarditis (IE). This is supported by experimental endocarditis. On the other hand, case-control studies showed that IE could be caused by cumulative exposure to low-grade bacteremia occurring during daily activities. However, no experimental demonstration of this latter possibility exists. This study investigated the infectivity in animals of continuous low-grade bacteremia compared to that of brief high-grade bacteremia. Rats with aortic vegetations were inoculated with Streptococcus intermedius, Streptococcus gordonii or Staphylococcus aureus (strains Newman and P8). Animals were challenged with 10(3) to 10(6) CFU. Identical bacterial numbers were given by bolus (1 ml in 1 min) or continuous infusion (0.0017 ml/min over 10 h). Bacteremia was 50 to 1,000 times greater after bolus than during continuous inoculation. Streptococcal bolus inoculation of 10(5) CFU infected 63 to 100% vegetations compared to 30 to 71% infection after continuous infusion (P > 0.05). When increasing the inoculum to 10(6) CFU, bolus inoculation infected 100% vegetations and continuous infusion 70 to 100% (P > 0.05). S. aureus bolus injection of 10(3) CFU infected 46 to 57% valves. This was similar to the 53 to 57% infection rates produced by continuous infusion (P > 0.05). Inoculation of 10(4) CFU of S. aureus infected 80 to 100% vegetations after bolus and 60 to 75% after continuous infusion (P > 0.05). These results show that high-level bacteremia is not required to induce experimental endocarditis and support the hypothesis that cumulative exposure to low-grade bacteremia represents a genuine risk of IE in humans.

Entities:  

Mesh:

Year:  2011        PMID: 21321073      PMCID: PMC3088130          DOI: 10.1128/IAI.01208-10

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  44 in total

1.  Prevalence, intensity and nature of bacteraemia after toothbrushing.

Authors:  Victoria S Lucas; Gavin Gafan; Sarah Dewhurst; Graham J Roberts
Journal:  J Dent       Date:  2008-05-02       Impact factor: 4.379

2.  Analysis of the American Heart Association's recommendations for the prevention of infective endocarditis.

Authors:  A A Tzukert; E Leviner; R Benoliel; J Katz
Journal:  Oral Surg Oral Med Oral Pathol       Date:  1986-09

3.  How important are dental procedures as a cause of infective endocarditis?

Authors:  W G Guntheroth
Journal:  Am J Cardiol       Date:  1984-10-01       Impact factor: 2.778

4.  Formation of vegetations during infective endocarditis excludes binding of bacterial-specific host antibodies to Enterococcus faecalis.

Authors:  John K McCormick; Timothy J Tripp; Gary M Dunny; Patrick M Schlievert
Journal:  J Infect Dis       Date:  2002-03-11       Impact factor: 5.226

5.  Experimental bacterial endocarditis after dental extractions in rats with periodontitis.

Authors:  C D Overholser; P Moreillon; M P Glauser
Journal:  J Infect Dis       Date:  1987-01       Impact factor: 5.226

6.  Simulation of amoxicillin pharmacokinetics in humans for the prevention of streptococcal endocarditis in rats.

Authors:  U Fluckiger; P Moreillon; J Blaser; M Bickle; M P Glauser; P Francioli
Journal:  Antimicrob Agents Chemother       Date:  1994-12       Impact factor: 5.191

7.  Duration, prevalence and intensity of bacteraemia after dental extractions in children.

Authors:  G J Roberts; E C Jaffray; D A Spratt; A Petrie; C Greville; M Wilson; V S Lucas
Journal:  Heart       Date:  2006-02-17       Impact factor: 5.994

8.  Targeted immunotherapy for staphylococcal infections : focus on anti-MSCRAMM antibodies.

Authors:  Michael Otto
Journal:  BioDrugs       Date:  2008       Impact factor: 5.807

9.  Poor oral hygiene as a risk factor for infective endocarditis-related bacteremia.

Authors:  Peter B Lockhart; Michael T Brennan; Martin Thornhill; Bryan S Michalowicz; Jenene Noll; Farah K Bahrani-Mougeot; Howell C Sasser
Journal:  J Am Dent Assoc       Date:  2009-10       Impact factor: 3.634

Review 10.  Vaccination and passive immunisation against Staphylococcus aureus.

Authors:  Adam C Schaffer; Jean C Lee
Journal:  Int J Antimicrob Agents       Date:  2008-08-30       Impact factor: 5.283

View more
  14 in total

1.  Antibodies Targeting Hsa and PadA Prevent Platelet Aggregation and Protect Rats against Experimental Endocarditis Induced by Streptococcus gordonii.

Authors:  Stefano Mancini; Carmen Menzi; Frank Oechslin; Philippe Moreillon; José Manuel Entenza
Journal:  Infect Immun       Date:  2016-11-18       Impact factor: 3.441

Review 2.  Infective endocarditis.

Authors:  Yok-Ai Que; Philippe Moreillon
Journal:  Nat Rev Cardiol       Date:  2011-04-12       Impact factor: 32.419

Review 3.  Infective endocarditis prophylaxis: moving from dental prophylaxis to global prevention?

Authors:  C Chirouze; B Hoen; X Duval
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-02-23       Impact factor: 3.267

4.  Use of a human-like low-grade bacteremia model of experimental endocarditis to study the role of Staphylococcus aureus adhesins and platelet aggregation in early endocarditis.

Authors:  Tiago Rafael Veloso; Aziz Chaouch; Thierry Roger; Marlyse Giddey; Jacques Vouillamoz; Paul Majcherczyk; Yok-Ai Que; Valentin Rousson; Philippe Moreillon; José Manuel Entenza
Journal:  Infect Immun       Date:  2012-12-17       Impact factor: 3.441

5.  Oral Streptococcal Endocarditis, Oral Hygiene Habits, and Recent Dental Procedures: A Case-Control Study.

Authors:  Xavier Duval; Sarah Millot; Catherine Chirouze; Christine Selton-Suty; Vanessa Moby; Pierre Tattevin; Christophe Strady; Edouard Euvrard; Nelly Agrinier; Daniel Thomas; Bruno Hoen; François Alla
Journal:  Clin Infect Dis       Date:  2017-06-15       Impact factor: 9.079

6.  Elevated levels of circulating DNA in cardiovascular disease patients: metagenomic profiling of microbiome in the circulation.

Authors:  Vasudevan Dinakaran; Andiappan Rathinavel; Muthuirulan Pushpanathan; Ramamoorthy Sivakumar; Paramasamy Gunasekaran; Jeyaprakash Rajendhran
Journal:  PLoS One       Date:  2014-08-18       Impact factor: 3.240

Review 7.  From in vitro to in vivo Models of Bacterial Biofilm-Related Infections.

Authors:  David Lebeaux; Ashwini Chauhan; Olaya Rendueles; Christophe Beloin
Journal:  Pathogens       Date:  2013-05-13

8.  Streptococcus gordonii Type I Lipoteichoic Acid Contributes to Surface Protein Biogenesis.

Authors:  Bruno P Lima; Kelvin Kho; Brittany L Nairn; Julia R Davies; Gunnel Svensäter; Ruoqiong Chen; Amanda Steffes; Gerrit W Vreeman; Timothy C Meredith; Mark C Herzberg
Journal:  mSphere       Date:  2019-12-04       Impact factor: 4.389

Review 9.  Aspirin Effect on Staphylococcus aureus-Platelet Interactions During Infectious Endocarditis.

Authors:  Nadji Hannachi; Gilbert Habib; Laurence Camoin-Jau
Journal:  Front Med (Lausanne)       Date:  2019-10-15

10.  Dental procedures, antibiotic prophylaxis, and endocarditis among people with prosthetic heart valves: nationwide population based cohort and a case crossover study.

Authors:  Sarah Tubiana; Pierre-Olivier Blotière; Bruno Hoen; Philippe Lesclous; Sarah Millot; Jérémie Rudant; Alain Weill; Joel Coste; François Alla; Xavier Duval
Journal:  BMJ       Date:  2017-09-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.